BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17976922)

  • 1. Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice.
    Steiner MA; Marsicano G; Nestler EJ; Holsboer F; Lutz B; Wotjak CT
    Psychoneuroendocrinology; 2008 Jan; 33(1):54-67. PubMed ID: 17976922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice.
    Steiner MA; Wanisch K; Monory K; Marsicano G; Borroni E; Bächli H; Holsboer F; Lutz B; Wotjak CT
    Pharmacogenomics J; 2008 Jun; 8(3):196-208. PubMed ID: 17684478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis.
    Hill MN; Ho WS; Sinopoli KJ; Viau V; Hillard CJ; Gorzalka BB
    Neuropsychopharmacology; 2006 Dec; 31(12):2591-9. PubMed ID: 16710317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant-induced undesirable weight gain: prevention with rimonabant without interference with behavioral effectiveness.
    Gobshtis N; Ben-Shabat S; Fride E
    Eur J Pharmacol; 2007 Jan; 554(2-3):155-63. PubMed ID: 17116301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence against a critical role of CB1 receptors in adaptation of the hypothalamic-pituitary-adrenal axis and other consequences of daily repeated stress.
    Rabasa C; Pastor-Ciurana J; Delgado-Morales R; Gómez-Román A; Carrasco J; Gagliano H; García-Gutiérrez MS; Manzanares J; Armario A
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1248-59. PubMed ID: 26092203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional cannabinoid receptor type 1 mutants reveal neuron subpopulation-specific effects on behavioral and neuroendocrine stress responses.
    Steiner MA; Marsicano G; Wotjak CT; Lutz B
    Psychoneuroendocrinology; 2008 Sep; 33(8):1165-70. PubMed ID: 18653287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression.
    Shen Q; Lal R; Luellen BA; Earnheart JC; Andrews AM; Luscher B
    Biol Psychiatry; 2010 Sep; 68(6):512-20. PubMed ID: 20579975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test.
    Hill MN; Gorzalka BB
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):593-9. PubMed ID: 15916883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protracted cannabinoid administration elicits antidepressant behavioral responses in rats: role of gender and noradrenergic transmission.
    Morrish AC; Hill MN; Riebe CJ; Gorzalka BB
    Physiol Behav; 2009 Aug; 98(1-2):118-24. PubMed ID: 19414024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential response to acute and repeated stress in cannabinoid CB1 receptor knockout newborn and adult mice.
    Fride E; Suris R; Weidenfeld J; Mechoulam R
    Behav Pharmacol; 2005 Sep; 16(5-6):431-40. PubMed ID: 16148448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice.
    Roberts CJ; Stuhr KL; Hutz MJ; Raff H; Hillard CJ
    Pharmacol Biochem Behav; 2014 Feb; 117():17-24. PubMed ID: 24316201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid CB₁ receptor in the modulation of stress coping behavior in mice: the role of serotonin and different forebrain neuronal subpopulations.
    Häring M; Grieb M; Monory K; Lutz B; Moreira FA
    Neuropharmacology; 2013 Feb; 65():83-9. PubMed ID: 23000076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test.
    Connor TJ; Kelliher P; Shen Y; Harkin A; Kelly JP; Leonard BE
    Pharmacol Biochem Behav; 2000 Apr; 65(4):591-7. PubMed ID: 10764911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid CB1 receptor antagonism modulates plasma corticosterone in rodents.
    Wade MR; Degroot A; Nomikos GG
    Eur J Pharmacol; 2006 Dec; 551(1-3):162-7. PubMed ID: 17030030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.
    Zádor F; Lénárt N; Csibrány B; Sántha M; Molnár M; Tuka B; Samavati R; Klivényi P; Vécsei L; Marton A; Vizler C; Nagy GM; Borsodi A; Benyhe S; Páldy E
    Neuropharmacology; 2015 Feb; 89():298-307. PubMed ID: 25446673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1 receptor inverse agonist AM-251 after physical stress in mice.
    Ostadhadi S; Haj-Mirzaian A; Nikoui V; Kordjazy N; Dehpour AR
    Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):203-12. PubMed ID: 26609670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice.
    Shearman LP; Rosko KM; Fleischer R; Wang J; Xu S; Tong XS; Rocha BA
    Behav Pharmacol; 2003 Dec; 14(8):573-82. PubMed ID: 14665974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased water temperature renders single-housed C57BL/6J mice susceptible to antidepressant treatment in the forced swim test.
    Bächli H; Steiner MA; Habersetzer U; Wotjak CT
    Behav Brain Res; 2008 Feb; 187(1):67-71. PubMed ID: 17923159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local enhancement of cannabinoid CB1 receptor signalling in the dorsal hippocampus elicits an antidepressant-like effect.
    McLaughlin RJ; Hill MN; Morrish AC; Gorzalka BB
    Behav Pharmacol; 2007 Sep; 18(5-6):431-8. PubMed ID: 17762511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents.
    Griebel G; Stemmelin J; Scatton B
    Biol Psychiatry; 2005 Feb; 57(3):261-7. PubMed ID: 15691527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.